GHA Medical Overview
- Year Founded
-
2005
- Status
-
Private
- Employees
-
50
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$7.64M
- Investors
-
5
GHA Medical General Information
Description
Developer of health information statistics system and technology. The company's health information product is non-invasive and does not need to puncture the skin to get the information needed, reducing the risk of infection; the measurements are stored effectively and shows blood sugar changes enabling users to conveniently keep track of their blood sugar levels avoiding the risk of infections.
Contact Information
Website
www.ghalife.comCorporate Office
- 808, Building 2, Runshi Center
- No. 16 Tianze Road, Chaoyang District
- Beijing
- China
Corporate Office
- 808, Building 2, Runshi Center
- No. 16 Tianze Road, Chaoyang District
- Beijing
- China
GHA Medical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Later Stage VC (Series A) | 25-Apr-2021 | $7.64M | Completed | Generating Revenue | ||
| 2. Later Stage VC | 04-Apr-2018 | Completed | Generating Revenue | |||
| 1. Later Stage VC | 13-Jun-2017 | Completed | Generating Revenue |
GHA Medical Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
GHA Medical Patents
GHA Medical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4218569-A1 | Photoplethysmography-based non-invasive diabetes prediction system and method | Pending | 22-Sep-2020 | ||
| EP-4218569-A4 | Photoplethysmography-based non-invasive diabetes prediction system and method | Pending | 22-Sep-2020 | ||
| US-10825569-B2 | Universal non-invasive blood glucose estimation method based on time series analysis | Active | 16-Dec-2016 | ||
| EP-3358485-A1 | General noninvasive blood glucose prediction method based on timing analysis | Pending | 16-Dec-2016 | ||
| US-20190295729-A1 | Universal non-invasive blood glucose estimation method based on time series analysis | Active | 16-Dec-2016 | G16H50/50 |
GHA Medical Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
GHA Medical Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| China Venture Capital | Venture Capital | Minority | ||
| Fortune Capital | Venture Capital | Minority | ||
| Tasly Capital | Corporate Venture Capital | Minority | ||
| General Technology Venture Capital | Venture Capital | Minority | ||
| Shineland Capital | Venture Capital | Minority |
GHA Medical FAQs
-
When was GHA Medical founded?
GHA Medical was founded in 2005.
-
Where is GHA Medical headquartered?
GHA Medical is headquartered in Beijing, China.
-
What is the size of GHA Medical?
GHA Medical has 50 total employees.
-
What industry is GHA Medical in?
GHA Medical’s primary industry is Monitoring Equipment.
-
Is GHA Medical a private or public company?
GHA Medical is a Private company.
-
What is GHA Medical’s current revenue?
The current revenue for GHA Medical is .
-
How much funding has GHA Medical raised over time?
GHA Medical has raised $7.64M.
-
Who are GHA Medical’s investors?
China Venture Capital, Fortune Capital, Tasly Capital, General Technology Venture Capital, and Shineland Capital have invested in GHA Medical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
